Hepatocyte Growth Factors (HGFs) Market Size to Hit USD 122.65 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hepatocyte Growth Factors (HGFs) Market

5.1. COVID-19 Landscape: Hepatocyte Growth Factors (HGFs) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hepatocyte Growth Factors (HGFs) Market, By Product Type

8.1. Hepatocyte Growth Factors (HGFs) Market Revenue and Volume, by Product Type

8.1.1. Recombinant Hepatocyte Growth Factors

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Natural HGFs (Purified from Biological Sources)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Synthetic Peptide Derivatives

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. HGF Gene Therapy Products

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Hepatocyte Growth Factors (HGFs) Market, By Application

9.1. Hepatocyte Growth Factors (HGFs) Market Revenue and Volume, by Application

9.1.1. Regenerative Medicine

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Oncology

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cell Therapy & Stem Cell Research

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Toxicology and Preclinical Drug Testing

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Organ Transplantation Support

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global Hepatocyte Growth Factors (HGFs) Market, By End User

10.1. Hepatocyte Growth Factors (HGFs) Market Revenue and Volume, by End User

10.1.1. Pharmaceutical & Biotechnology Companies

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Academic & Research Institutes

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. CROs (Contract Research Organizations)

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Hospitals & Transplant Centers

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Hepatocyte Growth Factors (HGFs) Market, By Delivery Mechanism

11.1. Hepatocyte Growth Factors (HGFs) Market Revenue and Volume, by Delivery Mechanism

11.1.1. Protein-Based Delivery (Recombinant)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Gene Therapy (Plasmid/Vector Delivery)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. mRNA-Based Delivery

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Cell-Based Delivery (Genetically Modified Cells)

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Hepatocyte Growth Factors (HGFs) Market, By May

12.1. Hepatocyte Growth Factors (HGFs) Market Revenue and Volume, by May

12.1.1. Human-Derived

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Animal-Derived

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Synthetic/Engineered Sources

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Hepatocyte Growth Factors (HGFs) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Application

13.1.3. Market Revenue and Volume Forecast, by End User

13.1.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.1.5. Market Revenue and Volume Forecast, by May

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Application

13.1.6.3. Market Revenue and Volume Forecast, by End User

13.1.6.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.1.6.5. Market Revenue and Volume Forecast, by May

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Application

13.1.7.3. Market Revenue and Volume Forecast, by End User

13.1.7.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.1.7.5. Market Revenue and Volume Forecast, by May

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Application

13.2.3. Market Revenue and Volume Forecast, by End User

13.2.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.2.5. Market Revenue and Volume Forecast, by May

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Application

13.2.6.3. Market Revenue and Volume Forecast, by End User

13.2.7. Market Revenue and Volume Forecast, by Delivery Mechanism

13.2.8. Market Revenue and Volume Forecast, by May

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Application

13.2.9.3. Market Revenue and Volume Forecast, by End User

13.2.10. Market Revenue and Volume Forecast, by Delivery Mechanism

13.2.11. Market Revenue and Volume Forecast, by May

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Application

13.2.12.3. Market Revenue and Volume Forecast, by End User

13.2.12.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.2.13. Market Revenue and Volume Forecast, by May

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Application

13.2.14.3. Market Revenue and Volume Forecast, by End User

13.2.14.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.2.15. Market Revenue and Volume Forecast, by May

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Application

13.3.3. Market Revenue and Volume Forecast, by End User

13.3.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.3.5. Market Revenue and Volume Forecast, by May

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Application

13.3.6.3. Market Revenue and Volume Forecast, by End User

13.3.6.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.3.7. Market Revenue and Volume Forecast, by May

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Application

13.3.8.3. Market Revenue and Volume Forecast, by End User

13.3.8.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.3.9. Market Revenue and Volume Forecast, by May

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Application

13.3.10.3. Market Revenue and Volume Forecast, by End User

13.3.10.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.3.10.5. Market Revenue and Volume Forecast, by May

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Application

13.3.11.3. Market Revenue and Volume Forecast, by End User

13.3.11.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.3.11.5. Market Revenue and Volume Forecast, by May

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Application

13.4.3. Market Revenue and Volume Forecast, by End User

13.4.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.4.5. Market Revenue and Volume Forecast, by May

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Application

13.4.6.3. Market Revenue and Volume Forecast, by End User

13.4.6.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.4.7. Market Revenue and Volume Forecast, by May

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Application

13.4.8.3. Market Revenue and Volume Forecast, by End User

13.4.8.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.4.9. Market Revenue and Volume Forecast, by May

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Application

13.4.10.3. Market Revenue and Volume Forecast, by End User

13.4.10.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.4.10.5. Market Revenue and Volume Forecast, by May

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Application

13.4.11.3. Market Revenue and Volume Forecast, by End User

13.4.11.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.4.11.5. Market Revenue and Volume Forecast, by May

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Application

13.5.3. Market Revenue and Volume Forecast, by End User

13.5.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.5.5. Market Revenue and Volume Forecast, by May

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Application

13.5.6.3. Market Revenue and Volume Forecast, by End User

13.5.6.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.5.7. Market Revenue and Volume Forecast, by May

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Application

13.5.8.3. Market Revenue and Volume Forecast, by End User

13.5.8.4. Market Revenue and Volume Forecast, by Delivery Mechanism

13.5.8.5. Market Revenue and Volume Forecast, by May

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lonza Group

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Merck KGaA (MilliporeSigma)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. F. Hoffmann-La Roche Ltd

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Takara Bio Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. GenScript Biotech Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Miltenyi Biotec

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. PeproTech (a Bio-Techne brand)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Abcam plc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. ReproCELL Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The hepatocyte growth factors (HGFs) market size is expected to increase from USD 72.76 million in 2024 to USD 122.65 million by 2034.

The hepatocyte growth factors (HGFs) market is expected to grow at a compound annual growth rate (CAGR) of around 5.36% from 2025 to 2034.

The major players in the hepatocyte growth factors (HGFs) market include Thermo Fisher Scientific, Lonza Group, Merck KGaA (MilliporeSigma), F. Hoffmann-La Roche Ltd, Takara Bio Inc., GenScript Biotech Corporation, Miltenyi Biotec, PeproTech (a Bio-Techne brand), Abcam plc, ReproCELL Inc., STEMCELL Technologies, Creative BioMart, Sino Biological Inc., Cell Signaling Technology, R&D Systems (Bio-Techne), Origene Technologies, ACROBiosystems, BioVision Inc., Creative Biolabs, and Eli Lilly and Company (for gene therapy pipelines involving HGF).

The driving factors of the hepatocyte growth factors (HGFs) market are the rising incidence of liver disorders and increased research into regenerative medicine. Advancements in cell-based therapies, which show promise for tissue repair and organ regeneration, and growing clinical applications of HGFs for liver and kidney diseases are expected to drive market growth in the coming years.

North America region will lead the global hepatocyte growth factors (HGFs) market during the forecast period 2025 to 2034.